Sentences with phrase «microfluidic platform»

A microfluidic platform refers to a tiny device that controls and manipulates small amounts of liquids, such as blood or chemicals, at a very tiny scale. It is often used in scientific research, medical diagnostics, and drug development to perform various experiments efficiently and accurately. Full definition
AMSBIO and the University of Strathclyde (Glasgow, UK) have pioneered a multidisciplinary approach combining expertise in microfluidics and 3D culture to develop a novel microfluidic platform for cancer research.
The new microfluidic platform technology is superior to animal testing, according to Griffith:
However, using a specially designed microfluidics platform, we discovered that the high osmotic potential is located at the tubule front edge.
MIT bioengineers have developed a new microfluidic platform technology that could be used to evaluate new drugs and detect possible side effects before the drugs are tested in humans.
To facilitate these approaches, novel microfluidic platforms automating the separation of daughter cells away from their mothers will be used.
Fussenegger's group developed the genetic network; Professor of Biosystems Engineering Andreas Hierlemann and his team tested the acidity sensor with the aid of microfluidic platforms; and Jörg Stelling, a professor of computational systems biology, modelled it in order to estimate the dynamics of the insulin production.
A Vector - Free Microfluidic Platform for Intracellular Delivery.
As this preparatory step can be time - consuming, it would be advantageous if microfluidic platforms could come pre-prepared with specific biomolecules sealed inside.
The results, published in Nanoscale, have profound implications for healthcare diagnostics and open up opportunities for producing pre-packaged microfluidic platform blood or urine testing devices.
This novel nMIS sensor could be used to create microfluidic platforms that test for various diseases.
Here, we report an approach to co-culture multiple different MPSs linked together physiologically on re-useable, open - system microfluidic platforms that are compatible with the quantitative study of a range of compounds, including lipophilic drugs.
The new microfluidic platform shows great promise to provide a cost - effective approach to applications including high - throughput drug screening, analysis and bioassays to assess spheroid function and morphology.
As part of his post-doctoral research at University of Chicago he co-invented the SlipChip - a multiplexed microfluidic platform for high - throughput droplet - based chemistry and biochemistry without pumps or valves.
There will be demand for really good people in developing new instrumentation, particularly as they move toward nanotechnology and microfluidics platforms.
Jenny Hu's thesis, «A Microfluidic Platform for High Throughput Biological Assays,» is about a technique to make quick, cheap genetic tests.
MIT engineers have designed a microfluidic platform that connects engineered tissue from up to 10 organs, allowing them to replicate human - organ interactions.
Using a microfluidic platform that connects engineered tissues from up to 10 organs, the researchers can accurately replicate human organ interactions for weeks at a time, allowing them to measure the effects of drugs on different parts of the body.
Measuring two fundamental properties of surface chemical reactions on the same device means that researchers can be far more confident that biomolecules have been successfully encapsulated within the microfluidic platform.
Microfluidic platforms have revolutionized medical diagnostics in recent years.
Based on this change, you can use this technique to measure the mass of the biomolecule, and confirm whether it survives exposure to ionized gas during encapsulation within the microfluidic platform.
Before the sample can be tested however, doctors need to insert specific disease - detecting biomolecules into the microfluidic platform.
To measure the effects of drugs on different parts of the body, MIT's new «Physiome - on - a-chip» microfluidic platform can connect 3D tissues from up to 10 «organs on chips» — allowing researchers to accurately replicate human - organ interactions for weeks at a time.
This microfluidic platform has enabled modulation of cell functions that were previously inaccessible.
Our microfluidic platform delivers precise control over the cellular microenvironment and beneficially through miniaturization, maximizes use of precious limited human cancer samples.
The microfluidic platform can connect 3D tissues from up to 10 organs.
The microfluidic platform delivers precise control over the cellular microenvironment and beneficially through miniaturization, maximizes use of precious limited human cancer samples.
To enable customized data analysis of the results from the microfluidic platform, our academic team has also developed a suite of easy - to - use software tools.
a b c d e f g h i j k l m n o p q r s t u v w x y z